Raphael Pharmaceutical Inc. (RAPH) Form 10-Q Quarterly Reports
Raphael Pharmaceutical Inc. (RAPH) is a publicly traded company on the OTC, categorized under SIC 2833 (Medicinal Chemicals & Botanical Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RAPH
CIK: 1415397
Exchange: OTC
SIC 2833: Medicinal Chemicals & Botanical Products
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Elkana Amitai CPA
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerElkana Amitai
Audit LocationMitzpe Netofa, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-01 | 2026-07-30 | CURRENT REPORT | 0001213900-26-096113 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-089975 | View SEC Doc Filr Page |
| 8-K | 2026-07-17 | 2026-07-16 | CURRENT REPORT | 0001213900-26-078937 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-056181 | View SEC Doc Filr Page |
| 4 | 2026-04-06 | 2025-11-20 | 4 Filing | 0001213900-26-040590 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-037402 | View SEC Doc Filr Page |
| 8-K | 2026-03-24 | 2025-12-31 | CURRENT REPORT | 0001213900-26-033507 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | QUARTERLY REPORT | 0001213900-25-109968 | View SEC Doc Filr Page |
| 3 | 2025-09-08 | 2025-08-01 | OWNERSHIP DOCUMENT | 0001213900-25-085537 | View SEC Doc Filr Page |
| 10-Q | 2025-08-13 | 2025-06-30 | QUARTERLY REPORT | 0001213900-25-075662 | View SEC Doc Filr Page |
| 8-K | 2025-08-11 | 2025-07-31 | CURRENT REPORT | 0001213900-25-074293 | View SEC Doc Filr Page |
| 8-K | 2025-08-11 | 2025-08-07 | CURRENT REPORT | 0001213900-25-073909 | View SEC Doc Filr Page |
| 10-Q | 2025-05-15 | 2025-03-31 | QUARTERLY REPORT | 0001213900-25-043641 | View SEC Doc Filr Page |
| 10-K | 2025-03-31 | 2024-12-31 | ANNUAL REPORT | 0001213900-25-026214 | View SEC Doc Filr Page |
| 4 | 2025-03-12 | 2022-05-12 | 4 Filing | 0001213900-25-023367 | View SEC Doc Filr Page |
| 4 | 2025-03-11 | 2025-03-02 | 4 Filing | 0001213900-25-022736 | View SEC Doc Filr Page |
| 4 | 2025-03-06 | 2025-03-05 | 4 Filing | 0001213900-25-021172 | View SEC Doc Filr Page |
| 3 | 2025-02-13 | 2025-01-08 | 3 Filing | 0001213900-25-013687 | View SEC Doc Filr Page |
| 8-K | 2025-01-14 | 2025-01-08 | CURRENT REPORT | 0001213900-25-003401 | View SEC Doc Filr Page |
| 8-K | 2024-12-30 | 2024-12-23 | CURRENT REPORT | 0001213900-24-113467 | View SEC Doc Filr Page |
| 424B3 | 2024-11-21 | — | PROSPECTUS SUPPLEMENT | 0001213900-24-100968 | View SEC Doc Filr Page |
| 10-Q | 2024-11-14 | 2024-09-30 | QUARTERLY REPORT | 0001213900-24-098456 | View SEC Doc Filr Page |
| EFFECT | 2024-09-26 | — | EFFECT Filing | 9999999995-24-002976 | View SEC Doc Filr Page |
| CORRESP | 2024-09-24 | — | CORRESP Filing | 0001213900-24-081436 | View SEC Doc Filr Page |
| UPLOAD | 2024-09-23 | — | UPLOAD Filing | 0000000000-24-010774 | View SEC Doc Filr Page |